Loss of p16 in advanced stage epithelial ovarian cancer is associated with chemoresistant disease, suboptimal debulking and poor progression-free survival: A Gynecologic Oncology Group study.

✍ Scribed by A. Wallace; K. Darcy; A. Alvarez-Secord; A. Hutson; D. Tritchler; L. Kirchgraber; L. Grace; R. Whitaker; A. Berchuck; L. Havrilesky

• Book ID: 113963639
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 65 KB
• Volume: 125
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2011.12.084